about
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot studyCerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosisAntibody biomarkers in CNS demyelinating diseases - a long and winding roadFulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathologyChildren with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseasesMultiple sclerosis: disease biomarkers as indicated by pathophysiologyNogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitisMOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeDiagnostic biomarkers in multiple sclerosis.Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis--results from a large population-based study.Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Nogo-B is associated with cytoskeletal structures in human monocyte-derived macrophages.Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics.Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults.MOG antibody-associated diseasesNeuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.Comparison of diagnostic accuracy of microscopy and flow cytometry in evaluating N-methyl-D-aspartate receptor antibodies in serum using a live cell-based assay.Nogo receptor is involved in the adhesion of dendritic cells to myelin.Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disordersAnti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritisNMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational StudyAntibodies to aquaporin-1 are not present in neuromyelitis optica.Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS.Antibodies as biological markers for pathophysiological processes in MS.Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.Isolation and analysis of a linear plasmid-located gene of Borrelia burgdorferi B29 encoding a 27 kDa surface lipoprotein (P27) and its overexpression in Escherichia coli.Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the diseaseMyelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disordersOpposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria.Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SDIntrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive ratsMulticentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
P50
Q21034132-813EAD2B-63E4-4418-928E-EB6C361B7FC4Q21144285-5E4D64FB-17DF-49B2-9EC0-357358F92AD0Q28262403-D328BD8A-8473-4A80-8CDD-D228218F321DQ28270042-0782EFB3-855E-4A8E-B64E-5D40E7E9E1C6Q28273255-D0BFB898-E9A2-4CBA-97E0-5512E043BE9BQ28293497-2014017E-6EDD-4BFD-9563-35ED98854240Q28742885-D60F35A1-4653-4C29-8530-A216945C3605Q30371412-72FEC977-39C7-48C7-83B9-F95056C742E8Q30598338-3551D4ED-C38A-41B7-A0A1-32481E67A8FDQ33302128-C7170218-6548-4755-BA02-145163913D69Q33576962-7D5495DA-12BE-4283-86A9-5E450A993BD3Q33576962-BDABF6A6-4117-4503-A5F2-F60320A04938Q33591024-B75A3A76-CAB9-4C18-AE62-C594769A1852Q33645795-81AB0CB5-8566-480C-859B-100D8FA14F78Q33793440-F03892BA-CCE1-4DA1-AC1D-612E5CA59E04Q34451130-9778E534-6043-4041-9B5D-DF4AE6DD7B2AQ34513731-7034CC07-3CF2-46F7-B53F-65F1ED2CF860Q34653997-D1248300-3D39-4EC1-9AB5-6BF51AD1D9EEQ34657019-833A4547-2271-4C41-B2C5-F694016C6491Q35023345-233FE757-CA74-4042-8466-F7A4228A800DQ35041447-1E5BFBED-ACF7-492A-8273-61102A1E35BCQ35208073-7010DB7E-92AB-43D6-8050-7FBADD8FB501Q35224250-6A3C6998-43E5-47E2-8102-B4A866F39E45Q35225938-975A7AA8-2AD6-4534-86BC-5BAE18A9AACDQ35753620-52654167-FA51-4E72-889B-1A91AE7A8C59Q35833865-0D769D21-226B-494A-94ED-C7B74CFD9A85Q35956155-18E2FCBD-211E-470F-93DA-72D341226186Q35962565-5A6CBD7C-5A71-48C0-877B-26D6AA5FFE26Q36071620-AB33423A-BD63-4552-AC54-AA93B646E900Q36118318-E55E01A7-7713-421F-9567-20D48F4AB6E9Q36303835-2D016DA4-20B9-4295-9897-69B66A2ACF51Q36578093-A05C25AD-9BD7-4C07-B5E2-058B42BECA5CQ36742838-C19F45BB-7BD3-49F4-828D-88FB015CCC09Q36768092-DF2BFD1B-E44F-4431-98FD-75D90F9D9894Q36778227-8789B0F9-B566-4B1C-9ED6-2EBB2FEFBB7DQ37014400-BD5A69AD-501D-4C4E-9028-BAD3EFC207F6Q37059594-3B3B7CD9-25F3-4D20-BB95-FCDE97477FC8Q37071264-6BD51EEB-0B51-4FDF-ACEA-9C666DBC6FBCQ37160320-EC60FB59-8E54-41C4-B7BC-3AD1679A3FEDQ37180238-0199D876-2196-47AB-AE8F-5EDD7DC2CE28
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Markus Reindl
@ast
Markus Reindl
@en
Markus Reindl
@es
Markus Reindl
@nl
Markus Reindl
@sl
type
label
Markus Reindl
@ast
Markus Reindl
@en
Markus Reindl
@es
Markus Reindl
@nl
Markus Reindl
@sl
prefLabel
Markus Reindl
@ast
Markus Reindl
@en
Markus Reindl
@es
Markus Reindl
@nl
Markus Reindl
@sl
P106
P21
P214
7389152637785220220000
P31
P496
0000-0003-2817-1402
P735
P7859
viaf-7389152637785220220000